Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC27188377;8378;8379 chr2:178770640;178770639;178770638chr2:179635367;179635366;179635365
N2AB27188377;8378;8379 chr2:178770640;178770639;178770638chr2:179635367;179635366;179635365
N2A27188377;8378;8379 chr2:178770640;178770639;178770638chr2:179635367;179635366;179635365
N2B26728239;8240;8241 chr2:178770640;178770639;178770638chr2:179635367;179635366;179635365
Novex-126728239;8240;8241 chr2:178770640;178770639;178770638chr2:179635367;179635366;179635365
Novex-226728239;8240;8241 chr2:178770640;178770639;178770638chr2:179635367;179635366;179635365
Novex-327188377;8378;8379 chr2:178770640;178770639;178770638chr2:179635367;179635366;179635365

Information

  • RefSeq wild type amino acid: V
  • RefSeq wild type transcript codon: GTG
  • RefSeq wild type template codon: CAC
  • Domain: Ig-17
  • Domain position: 12
  • Structural Position: 16
  • Q(SASA): 0.3481
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
V/A rs2091324546 None 0.999 D 0.481 0.667 0.746317035393 gnomAD-4.0.0 1.59126E-06 None None None None I None 0 0 None 0 0 None 0 0 0 1.43287E-05 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
V/A 0.5541 ambiguous 0.6973 pathogenic -0.501 Destabilizing 0.999 D 0.481 neutral D 0.54989227 None None I
V/C 0.9481 likely_pathogenic 0.9631 pathogenic -0.519 Destabilizing 1.0 D 0.686 prob.neutral None None None None I
V/D 0.9868 likely_pathogenic 0.9927 pathogenic -0.266 Destabilizing 1.0 D 0.719 prob.delet. None None None None I
V/E 0.9493 likely_pathogenic 0.9618 pathogenic -0.393 Destabilizing 1.0 D 0.652 neutral D 0.703029302 None None I
V/F 0.8528 likely_pathogenic 0.8979 pathogenic -0.83 Destabilizing 1.0 D 0.698 prob.neutral None None None None I
V/G 0.8223 likely_pathogenic 0.9056 pathogenic -0.622 Destabilizing 1.0 D 0.682 prob.neutral D 0.702944807 None None I
V/H 0.9906 likely_pathogenic 0.9935 pathogenic -0.296 Destabilizing 1.0 D 0.715 prob.delet. None None None None I
V/I 0.1356 likely_benign 0.1589 benign -0.338 Destabilizing 0.998 D 0.515 neutral None None None None I
V/K 0.9557 likely_pathogenic 0.9593 pathogenic -0.374 Destabilizing 1.0 D 0.65 neutral None None None None I
V/L 0.7328 likely_pathogenic 0.7955 pathogenic -0.338 Destabilizing 0.997 D 0.517 neutral D 0.607329521 None None I
V/M 0.5489 ambiguous 0.6408 pathogenic -0.275 Destabilizing 1.0 D 0.725 prob.delet. D 0.701958867 None None I
V/N 0.9605 likely_pathogenic 0.9774 pathogenic -0.056 Destabilizing 1.0 D 0.718 prob.delet. None None None None I
V/P 0.9968 likely_pathogenic 0.9978 pathogenic -0.358 Destabilizing 1.0 D 0.684 prob.neutral None None None None I
V/Q 0.9382 likely_pathogenic 0.9515 pathogenic -0.332 Destabilizing 1.0 D 0.697 prob.neutral None None None None I
V/R 0.9433 likely_pathogenic 0.9478 pathogenic 0.131 Stabilizing 1.0 D 0.721 prob.delet. None None None None I
V/S 0.82 likely_pathogenic 0.9013 pathogenic -0.407 Destabilizing 1.0 D 0.659 neutral None None None None I
V/T 0.6036 likely_pathogenic 0.7102 pathogenic -0.437 Destabilizing 0.999 D 0.62 neutral None None None None I
V/W 0.9983 likely_pathogenic 0.9989 pathogenic -0.906 Destabilizing 1.0 D 0.713 prob.delet. None None None None I
V/Y 0.9877 likely_pathogenic 0.9919 pathogenic -0.591 Destabilizing 1.0 D 0.705 prob.neutral None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.